Evidence map›Paper›PMID 26671957›Full record

ArticleBMJ open2015

Bloodstream infections, antibiotic resistance and the practice of blood culture sampling in Germany: study design of a Thuringia-wide prospective population-based study (AlertsNet).

André Karch, Roland P Schmitz, Florian Rißner, Stefanie Castell, Sandra Töpel, Matthias Jakob, Frank M Brunkhorst, Rafael T Mikolajczyk

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

André KarchDepartment of Epidemiology, Helmholtz Centre for Infection Research, Braunschweig, Germany.ORCID http://orcid.org/0000-0003-3014-8543
Roland P SchmitzPaul-Martini Research Group, Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany.
Florian RißnerCenter for Clinical Studies Jena (ZKS), Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany.
Stefanie CastellDepartment of Epidemiology, Helmholtz Centre for Infection Research, Braunschweig, Germany.
Sandra TöpelPaul-Martini Research Group, Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany.
Matthias JakobPaul-Martini Research Group, Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany.
Frank M BrunkhorstPaul-Martini Research Group, Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany Center for Clinical Studies Jena (ZKS), Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany.
Rafael T MikolajczykDepartment of Epidemiology, Helmholtz Centre for Infection Research, Braunschweig, Germany.
Jena University Hospital · DEHelmholtz Centre for Infection Research · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionBloodstream infections are a major cause of death worldwide; blood culture (BC) sampling remains the most important tool for their diagnosis. Current data suggest that BC rates in German hospitals are considerably lower than recommended; this points to shortfalls in the application of microbiological analyses. Since early and appropriate BC diagnostics are associated with reduced case fatality rates and a shorter duration of antimicrobial therapy, a multicomponent study for the improvement of BC diagnostics was developed. METHODS AND ANALYSIS: An electronic BC registry established for the German Federal state of Thuringia is the structural basis of this study. The registry includes individual patient data (microbiological results and clinical data) and institutional information for all clinically relevant positive BCs at the participating centres. First, classic result quality indicators for bloodstream infections (eg, sepsis rates) will be studied using Poisson regression models (adjusted for institutional characteristics) in order to derive relative ranks for feedback to clinical institutions. Second, a target value will be established for the process indicator BC rate. On the basis of this target value, recommendations will be made for a given combination of institutional characteristics as a reference for future use in quality control. An interventional study aiming at the improvement of BC rates will be conducted thereafter. On the basis of the results of a survey in the participating institutions, a targeted educational intervention will be developed. The success of the educational intervention will be measured by changes in the process indicator and the result indicators over time using a pre-post design. ETHICS AND DISSEMINATION: Ethics approval was obtained from the Ethics committee of the University Hospital Jena and from the Ethics committee of the State Chamber of Physicians of Thuringia. Findings of AlertsNet will be disseminated through public media releases and publications in peer-reviewed journals. TRIAL REGISTRATION NUMBER: DRKS00004825.

Indexed as

Blood Specimen CollectionDrug Resistance, MicrobialResearch DesignBacteremiaGermanyHumansIntensive Care UnitsPopulation SurveillanceProspective StudiesRegistriesRegression AnalysisSepsisEPIDEMIOLOGYINTENSIVE & CRITICAL CAREPUBLIC HEALTH

Identifiers

PMID26671957
PMCPMC4679894
OpenAlexW2265782748

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.